Skip to main content
SpringerLink
Log in

Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

An Erratum to this article was published on 01 November 1998

Abstract

In this study, we evaluated low dose intravesical bacillus Calmette-Guerin (BCG) therapy following transurethral resection (TUR) in 80 patients with superficial bladder cancer. The patients were divided into two groups. Of the Connaught BCG strain 81 mg was given to 40 patients in Group 1 and 54 mg to the remainder of 40 patients in Group 2. BCG was introduced once a week for 6 weeks. Tumour recurrence was seen in 6 patients in Group 1 and in 10 patients in Group 2. Recurrence rates per month were 0.71 and 1.49, respectively. There was no significant difference in complication rates.

These data suggest that while the standard dose (81 mg) intravesical therapy of BCG is more effective than the low dose, there was no significant difference in side effects between the two groups.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Herr, H. W.: An overview of intravesical therapy for superficial bladder tumors.J. Urol., 16, 1363 (1987).

    Google Scholar 

  2. Soloway, M. S.: Selecting initial therapy for bladder cancer.Cancer, 60, 502 (1987).

    Article  PubMed  CAS  Google Scholar 

  3. Harry, W.: TUR and intravesical therapy of superficial bladder tumor.Urol. Oncol., 18, 525 (1991).

    Google Scholar 

  4. Stenberg, C. N., Scher, H. I.: Advances in the treatment of urothelia tumors.Urol. Clin. N. Am., 14, 373 (1987).

    Google Scholar 

  5. Morales, A.: Intracavitary BCG in treatment of superficial bladder tumor.J. Urol., 116, 180 (1976).

    PubMed  CAS  Google Scholar 

  6. Lamm, D. L.: A randomized prospective comparison of oral versus intracavitary BCG for superficial bladder tumor.J. Urol., 144, 65 (1990).

    PubMed  CAS  Google Scholar 

  7. Brosman, S. A., Lamm, D. L.: Handling and use of intravesical BCG for the management of stage Ta, T1, ca in situ and transitional bladder cancer.J. Urol., 144, 313 (1990).

    PubMed  CAS  Google Scholar 

  8. Haaff, E.: Two courses of intravesical bladder BCG for transitional cell ca.J. Urol., 136, 820 (1986).

    PubMed  CAS  Google Scholar 

  9. Kelley, D. R.: Intravesical BCG therapy for superficial bladder cancer.J. Urol., 136, 48 (1985).

    Google Scholar 

  10. Pagano, F.: Effectiveness of a low dose BCG therapy in superficial cancer.J. Urol., 141, 334 (1989).

    Google Scholar 

  11. Guinuan, P.: BCG in the management of superficial bladder cancer.Urology, 30, 16 (1991).

    Google Scholar 

  12. Lamm, D. L., Griffin, J. G.: Intravesical therapy.Semin. Urol., 10, 39 (1992).

    PubMed  CAS  Google Scholar 

  13. Cockett, A. T. K., Davis, R. S., Cos, L. R., Wheeless, L. L. Jr.: BCG and interleukin-2 for treatment of superficial bladder cancer.J. Urol., 146, 766 (1991).

    PubMed  CAS  Google Scholar 

  14. Pagano, F., Bessi, P.: A low dose BCG regimen in superficial bladder cancer therapy: Is it effective?J. Urol., 146, 32 (1991).

    PubMed  CAS  Google Scholar 

  15. Bast, R. C.: BCG and cancer.N. Engl. J. Med.,2 (1991).

Download references

Author information

Authors and Affiliations

  1. Social Security Council, Ankara Hospital, Ankara, Turkey

    F. Yalçinkaya, L. Kamiş, O. Özteke, B. Günlüsoy, O. Yiĝitbasi & S. Ünal

Authors
  1. F. Yalçinkaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Kamiş
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Özteke
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Günlüsoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. O. Yiĝitbasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Ünal
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/BF02564870.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yalçinkaya, F., Kamiş, L., Özteke, O. et al. Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer. International Urology and Nephrology 30, 41–44 (1998). https://doi.org/10.1007/BF02550276

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550276

Keywords

Search

Navigation